| Lymphocyte populations in Parkinson’s disease and in rat models of parkinsonism J Bas, M Calopa, M Mestre, DG Mollevı, B Cutillas, S Ambrosio, ... Journal of neuroimmunology 113 (1), 146-152, 2001 | 308 | 2001 |
| Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment E Dotor, M Cuatrecases, M Martínez-Iniesta, M Navarro, F Vilardell, ... Journal of clinical oncology 24 (10), 1603-1611, 2006 | 170 | 2006 |
| Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information M Berdiel-Acer, R Sanz-Pamplona, A Calon, D Cuadras, A Berenguer, ... Molecular oncology 8 (7), 1290-1305, 2014 | 144 | 2014 |
| Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer R Sanz-Pamplona, A Berenguer, D Cordero, DG Molleví, M Crous-Bou, ... Molecular cancer 13, 1-19, 2014 | 140 | 2014 |
| Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancer A Vidal, C Muñoz, MJ Guillén, J Moretó, S Puertas, M Martínez-Iniesta, ... Clinical Cancer Research 18 (19), 5399-5411, 2012 | 105 | 2012 |
| A vulnerability of a subset of colon cancers with potential clinical utility L Vecchione, V Gambino, J Raaijmakers, A Schlicker, A Fumagalli, ... Cell 165 (2), 317-330, 2016 | 103 | 2016 |
| Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency A Gros, J Martínez-Quintanilla, C Puig, S Guedan, DG Molleví, R Alemany, ... Cancer research 68 (21), 8928-8937, 2008 | 75 | 2008 |
| Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype A Aytes, DG Molleví, M Martinez‐Iniesta, M Nadal, A Vidal, A Morales, ... Molecular carcinogenesis 51 (9), 746-753, 2012 | 65 | 2012 |
| Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells S Gonçalves-Ribeiro, NG Díaz-Maroto, M Berdiel-Acer, A Soriano, ... Oncotarget 7 (37), 59766, 2016 | 56 | 2016 |
| PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness DG Molleví, A Aytes, L Padullés, M Martínez-Iniesta, N Baixeras, ... British journal of cancer 99 (10), 1718-1725, 2008 | 52 | 2008 |
| Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling S Gonçalves-Ribeiro, R Sanz-Pamplona, A Vidal, X Sanjuan, ... Annals of Oncology 28 (9), 2160-2168, 2017 | 49 | 2017 |
| Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection DG Molleví, T Serrano, MM Ginesta, J Valls, J Torras, M Navarro, ... Carcinogenesis 28 (6), 1241-1246, 2007 | 49 | 2007 |
| Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights E Latacz, D Höppener, A Bohlok, S Leduc, S Tabariès, C Fernandez Moro, ... British journal of cancer 127 (6), 988-1013, 2022 | 41 | 2022 |
| A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer M Berdiel-Acer, A Berenguer, R Sanz-Pamplona, D Cuadras, X Sanjuan, ... Oncotarget 5 (15), 6437, 2014 | 38 | 2014 |
| Noncanonical TGFβ pathway relieves the blockade of IL1β/TGFβ-mediated crosstalk between tumor and stroma: TGFBR1 and TAK1 inhibition in colorectal cancer N Guillen Diaz-Maroto, R Sanz-Pamplona, M Berdiel-Acer, FJ Cimas, ... Clinical Cancer Research 25 (14), 4466-4479, 2019 | 37 | 2019 |
| The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types P Micke, C Strell, J Mattsson, A Martín-Bernabé, H Brunnström, J Huvila, ... EBioMedicine 65, 2021 | 34 | 2021 |
| Hepatic Carcinoma—Associated Fibroblasts Promote an Adaptative Response in Colorectal Cancer Cells That Inhibit Proliferation and Apoptosis: Nonresistant Cells Die by … M Berdiel-Acer, ME Bohem, A López-Doriga, A Vidal, R Salazar, ... Neoplasia 13 (10), 931-946, 2011 | 32 | 2011 |
| Can medical imaging identify the histopathological growth patterns of liver metastases? E Latacz, PJ Van Dam, C Vanhove, L Llado, B Descamps, N Ruiz, I Joye, ... Seminars in Cancer Biology 71, 33-41, 2021 | 28 | 2021 |
| Orthoxenografts of testicular germ cell tumors demonstrate genomic changes associated with cisplatin resistance and identify PDMP as a resensitizing agent JM Piulats, A Vidal, FJ García-Rodríguez, C Munoz, M Nadal, C Moutinho, ... Clinical Cancer Research 24 (15), 3755-3766, 2018 | 21 | 2018 |
| A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasis M Berdiel-Acer, D Cuadras, NG Díaz-Maroto, X Sanjuan, T Serrano, ... Molecular cancer research 12 (9), 1254-1266, 2014 | 20 | 2014 |
